Public COA audit

Triple Agonist

Audited July 28, 2026

Mostly consistent, with concerns

Several fields check out, but we found issues worth reviewing before you rely on this document.

Legitimacy
92
Confidence
88%
Panels
5/7
Purity (printed)
99.81%

Document details

Fields extracted from the certificate — not order or payment data.

Batch / lot
CR26043XAG15-01
Identity method
HPLC
Sample date
2026-05-22
Issue date
2026-05-27

7-panel checklist

Had data + good, had data + bad, reported without pass/fail, or missing. Missing lowers thoroughness — you decide whether that panel matters; PeptIQ’s score still factors coverage.

5 of 7 present · 4 passed · 0 failed · 1 reported · 2 missing

Missing is a thoroughness gap — not automatically bad. PeptIQ’s legitimacy score still weighs panel coverage; you can down-weight panels that don’t matter for your use case.

  • Identity

    Tested · passed · core

    Compound identity confirmed (e.g. HPLC, mass spec).

    Confirmed

  • Purity

    Tested · passed · core

    Reported purity percentage for the analyte.

    99.81%

  • Heavy metals

    Tested · passed

    Lead, arsenic, cadmium, mercury, or similar limits.

    All Not Detected (As, Cd, Cr, Hg, Pb)

  • Microbial

    Not on this COA

    Bioburden / microbial limits testing.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

  • Endotoxin

    Tested · result on file · core

    LAL or chromogenic endotoxin assay.

    NMT 0.05 EU/mL

  • Sterility

    Tested · passed

    Sterility testing where applicable.

    No Growth

  • Residual solvent / water

    Not on this COA

    Residual solvents or water content limits.

    No evidence for this panel. That lowers thoroughness — whether it matters depends on what you care about.

How to read this

Had data · good

Panel present with a pass (or clear acceptance).

Had data · bad

Panel present with a fail — a concrete quality signal.

Had data · unclear

Value reported without an explicit pass/fail mark.

Missing

Not on this certificate. Lowers thoroughness; you decide if that panel matters for your use case. PeptIQ’s score still factors coverage.

Findings

Evidence-linked observations from this audit.

  • High purity confirmed

    99.81% purity by HPLC with conformity testing across 3 samples (mean 99.68%, std dev 0.0896%). Includes chromatogram and detailed methodology.

  • Identity confirmed

    Triple Agonist confirmed by HPLC retention time comparison with reference standard. Fentanyl screen negative.

  • Complete batch information

    Lot CR26043XAG15-01, COA COA-2026-ZJXM04, Accession ACC-2026-3002. Net peptide content 15.87 mg (target 15 mg).

  • Dates consistent

    Received 2026-05-22, analyzed 2026-05-27, issued 2026-05-27. All dates are logical and sequential.

  • Lab credentials present

    ILS Laboratories, San Diego CA. ISO/IEC 17025 accredited. Signed by Dr. Greg Kalyuzhny, Lab Director. Verification URL and QR code provided.

  • Comprehensive testing suite

    Includes purity/identity (HPLC), heavy metals (ICP-MS), sterility (PCR), endotoxin (USP <85>), and fentanyl screening. Missing only microbial count and residual solvents.

  • Professional presentation

    Well-formatted 2-page COA with detailed methodology notes, conformity testing table, chromatogram, and clear pass/fail indicators.

  • Lab verification recommended

    ILS Laboratories appears legitimate but independent verification of accreditation status and the provided verification URL is recommended for complete due diligence.

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.